SummaryPurposeTo assess the prevalence and determinants of non-adherence to antiretroviral therapy (ART) as well as the concordance of two screening criteria in a major center for human immunodeficiency virus (HIV) treatment in Yaounde, Cameroon.MethodsIn 2011, we conducted a cross-sectional study involving a random sample of 889 adults (age>18 years, 67.9% women) infected with HIV who were receiving chronic care at the Yaounde Jamot Hospital. Adherence was assessed via self-administered questionnaires using the Community Programs for Clinical Research on AIDS (CPCRA) index and the Center for Adherence Support Evaluation (CASE) index.ResultsThe prevalence of non-adherence to ART was 22.5% based on the CPCRA index and 34.9% based on the CASE...
Objectives: Antiretroviral treatment (ART) scale-up in sub-Saharan Africa has made it possible to in...
BACKGROUND: Scale-up of antiretroviral therapy (ART) in resource-limited settings has drastically re...
Rationale Since 2001, antiretroviral therapy (ART) for people living with HIV (PLHIV) has been avail...
Summary: Purpose: To assess the prevalence and determinants of non-adherence to antiretroviral ther...
SummaryPurposeTo assess the prevalence and determinants of non-adherence to antiretroviral therapy (...
Following global efforts to increase antiretroviral therapy (ART) access in Sub-Saharan Africa, ART ...
Background: Measurement of adherence to antiretroviral therapy (ART) can serve as a proxy for virolo...
Background: According to UNAIDS 2019, 52% of people worldwide living with HIV is on antiretrovirals ...
Abstract Background The benefits of antiretroviral therapy (ART) cannot be experienced if they are n...
Objective The rapid scale up of antiretroviral treatment (ART) in sub-Saharan Africa (SSA) has resul...
Thesis (Master's)--University of Washington, 2015Background Antiretroviral therapy (ART) requires a ...
Non-adherence is one of the major causes of treatment failure which leads to increased morbidity and...
Abstract Background Retention on lifelong antiretroviral therapy (ART) is essential in sustaining tr...
Objectives—To characterize antiretroviral therapy (ART) adherence across different programmes and ex...
Background: Scale-up of antiretroviral therapy (ART) in resource-limited settings has drastically re...
Objectives: Antiretroviral treatment (ART) scale-up in sub-Saharan Africa has made it possible to in...
BACKGROUND: Scale-up of antiretroviral therapy (ART) in resource-limited settings has drastically re...
Rationale Since 2001, antiretroviral therapy (ART) for people living with HIV (PLHIV) has been avail...
Summary: Purpose: To assess the prevalence and determinants of non-adherence to antiretroviral ther...
SummaryPurposeTo assess the prevalence and determinants of non-adherence to antiretroviral therapy (...
Following global efforts to increase antiretroviral therapy (ART) access in Sub-Saharan Africa, ART ...
Background: Measurement of adherence to antiretroviral therapy (ART) can serve as a proxy for virolo...
Background: According to UNAIDS 2019, 52% of people worldwide living with HIV is on antiretrovirals ...
Abstract Background The benefits of antiretroviral therapy (ART) cannot be experienced if they are n...
Objective The rapid scale up of antiretroviral treatment (ART) in sub-Saharan Africa (SSA) has resul...
Thesis (Master's)--University of Washington, 2015Background Antiretroviral therapy (ART) requires a ...
Non-adherence is one of the major causes of treatment failure which leads to increased morbidity and...
Abstract Background Retention on lifelong antiretroviral therapy (ART) is essential in sustaining tr...
Objectives—To characterize antiretroviral therapy (ART) adherence across different programmes and ex...
Background: Scale-up of antiretroviral therapy (ART) in resource-limited settings has drastically re...
Objectives: Antiretroviral treatment (ART) scale-up in sub-Saharan Africa has made it possible to in...
BACKGROUND: Scale-up of antiretroviral therapy (ART) in resource-limited settings has drastically re...
Rationale Since 2001, antiretroviral therapy (ART) for people living with HIV (PLHIV) has been avail...